Department of Medicine

April 4, 2013

Cancer studies reveal new genetic variants

The future of cancer is becoming clearer. And it’s not looking so good for cancer.

By Bill Snyder
April 4, 2013

Community involvement aids translational research

As Carla Sevin, M.D., assistant professor of Medicine at Vanderbilt, began the process of writing a recent grant proposal, she was stumped.

By Jessica Pasley
April 4, 2013

Vanderbilt researchers work to balance flu vaccine debate

Research in the last two years to examine the effectiveness of the influenza vaccine has raised public doubt about the flu shot’s effectiveness. But two Vanderbilt researchers co-wrote an editorial in the Journal of the American Medical Association (JAMA) recently to help balance the current debate.

By VUMC News and Communications
March 28, 2013

Foundation lauds graduate student’s melanoma research

Katherine Hutchinson, a third-year graduate student in Cancer Biology at Vanderbilt University, has won a $10,000 Research Scholar Award from the Joanna M. Nicolay Melanoma Foundation.

By Bill Snyder
March 21, 2013

New holders of endowed chairs honored

Seven Vanderbilt University faculty members named to endowed chairs were honored for outstanding academic achievements March 19 during a celebration at the Student Life Center.

By Bill Snyder
March 14, 2013

New center to focus on treating, preventing TB

Vanderbilt University has established a tuberculosis center to expand and extend efforts to improve the treatment and prevention of this often fatal disease here and around the world.

By Bill Snyder
March 14, 2013

Recruitments bolster personalized medicine initiative

VUMC’s personalized medicine effort is getting a major boost with the recruitment of two physician-scientists from Australia who will increase Vanderbilt’s strength in translational immunology, the translation of basic immunological discoveries into clinically useful tools.
By Nancy Humphrey
March 14, 2013

Heart failure therapy shows promise in early clinical trial

Vanderbilt University Medical Center and Acorda Therapeutics Inc. released findings from a Phase 1 clinical trial of glial growth factor 2 (GGF2) last week at the American College of Cardiology Annual Scientific Session in San Francisco.
By Kathy Whitney
February 28, 2013

Potent genetic risk factor for breast cancer identified

Researchers at Vanderbilt University have found a powerful new genetic risk factor for breast cancer.
By Bill Snyder
February 21, 2013

VU experts help craft AMA paper on safe transitions for patients

“There and Home Again, Safely: 5 Responsibilities of Ambulatory Practices in High Quality Care Transitions,” a new white paper from the American Medical Association (AMA), is the work of a 19-member expert panel that included two Vanderbilt faculty members — Sunil Kripalani, M.D., M.Sc., associate professor of Medicine, and Amanda Salanitro M.D., MS, MSPH, instructor in Medicine, both from the section of Hospital Medicine in the Department of Medicine’s Division of General Internal Medicine and Public Health.
By Paul Govern
February 6, 2013

Linking oxygen, iron and red blood cells

The HIF oxygen-sensing pathway and its responses to low oxygen may be targeted for treatments of anemia and disorders of iron balance.
By Leigh MacMillan
January 31, 2013

Vanderbilt, GE unite to study colon tumor development

Vanderbilt University has partnered with GE Global Research in Niskayuna, N.Y., the technology development arm of the General Electric Company, to better define — at the cellular level — how colon tumors form and develop.
By Bill Snyder
January 31, 2013

Do-it-yourself repair in the kidney

The kidney can mediate its own repair through proliferation of resident immune system cells.
By Leigh MacMillan